Consumer healthcare colossus Haleon dropped on Wednesday despite upgrading its sales guidance following strong first-half trading.
At 326.5p per share Haleon’s share price was 1.1% lower in cautious midweek business.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased